Thromb Haemost 2014; 112(04): 803-811
DOI: 10.1160/TH13-10-0865
Animal Models
Schattauer GmbH

L-selectin deficiency decreases aortic B1a and Breg subsets and promotes atherosclerosis

Breanne N. Gjurich
1   Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
,
Parésa L. Taghavie-Moghadam
1   Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
,
Klaus Ley
2   Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA
,
Elena V. Galkina
1   Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, Virginia, USA
› Author Affiliations
Financial support: This work was supported by NHLBI RO1HL107522 (to EG) and EVMS start-up funds. Received: October 22, 2013
Further Information

Publication History



Accepted after major revision: 29 April 2014

Publication Date:
04 December 2017 (online)

Summary

There is a significant recruitment of leucocytes into aortas during atherogenesis. L-selectin regulates leucocyte migration into secondary lymphoid and peripheral tissues and was proposed to play a role in leucocyte homing into aortas. Here, we determine the role of L-selectin in atherosclerosis. L-selectin-deficient Apoe -/- (Sell -/- Apoe -/-) mice had a 74% increase in plaque burden compared to Apoe -/- mice fed a chow diet for 50 weeks. Elevated atherosclerosis was accompanied by increased aortic leucocyte content, but a 50% reduction in aortic B cells despite elevated B cell counts in the blood. Follicular B cells represented 65%, whereas B1a and regulatory B cells (Breg) comprised 5% of aortic B cells. B1a and Breg cell subsets were reduced in Sell -/- Apoe -/- aortas with accompanied two-fold decrease in aortic T15 antibody and 1.2-fold decrease of interleukin-10 (IL-10) levels. L-selectin was required for B1 cell homing to the atherosclerotic aorta, as demonstrated by a 1.5-fold decrease in the migration of Sell -/- Apoe -/- vs Apoe -/- cells. Notably, we found a 1.6-fold increase in CD68hi macrophages in Sell -/- Apoe -/- compared to Apoe -/- aortas, despite comparable blood monocyte numbers and L-selectin-dependent aortic homing. L-selectin had no effect on neutrophil migration into aorta, but led to elevated blood neutrophil numbers, suggesting a potential involvement of neutrophils in atherogenesis of Sell -/- Apoe -/- mice. Thus, L-selectin deficiency increases peripheral blood neutrophil and lymphocyte numbers, decreases aortic B1a and Breg populations, T15 antibody and IL-10 levels, and increases aortic macrophage content of Sell -/- Apoe -/- mice. Altogether, these data provide evidence for an overall atheroprotective role of L-selectin.

 
  • References

  • 1 Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-212.
  • 2 Packard RR, Lichtman AH, Libby P. Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 2009; 31: 5-22.
  • 3 Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Ann Rev Immunol 2009; 27: 165-197.
  • 4 Butcher MJ, Galkina EV. Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front Physiol 2012; 3: 44.
  • 5 Mallat Z, Taleb S, Ait-Oufella H. et al. The role of adaptive T cell immunity in atherosclerosis. J Lipid Res 2009; 2: S364-S369.
  • 6 Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011; 145: 341-355.
  • 7 Perry HM, Bender TP, McNamara CA. B cell subsets in atherosclerosis. Front Immunol 2012; 3: 373.
  • 8 Ivetic A. Signals regulating L-selectin-dependent leucocyte adhesion and trans-migration. Int J Biochem Cell Biol 2013; 45: 550-555.
  • 9 Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004; 4: 325-335.
  • 10 Arbones ML, Ord DC, Ley K. et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994; 1: 247-260.
  • 11 von Andrian UH, Hasslen SR, Nelson RD. et al. A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell 1995; 82: 989-999.
  • 12 von Andria UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003; 3: 867-878.
  • 13 Galkina E, Kadl A, Sanders J. et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006; 203: 1273-1282.
  • 14 Rozenberg I, Sluka SH, Mocharla P. et al. Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS One 2011; 6: e21675.
  • 15 Morrison VL, Barr TA, Brown S. et al. TLR-mediated loss of CD62L focuses B cell traffic to the spleen during Salmonella typhimurium infection. J Immunol 2010; 185: 2737-2746.
  • 16 Corte-Real J, Duarte N, Tavares N. et al. Innate stimulation of B1a cells enhances the autoreactive IgM repertoire in the NOD mouse: implications for type 1 diabetes. Diabetologia 2012; 55: 1761-1772.
  • 17 Hart GT, Wang X, Hogquist KA. et al. Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proc Natl Acad Sci USA 2011; 108: 716-721.
  • 18 Binder CJ, Silverman GJ. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol 2005; 26: 385-404.
  • 19 Kyaw T, Tipping P, Toh BH. et al. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr Opin Lipidol 2011; 22: 373-379.
  • 20 Doran AC, Lipinski MJ, Oldham SN. et al. B-cell aortic homing and atheroprotection depend on Id3. Circ Res 2012; 110: e1-12.
  • 21 Caligiuri G, Nicoletti A, Poirier P. et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002; 109: 745-753.
  • 22 Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002; 22: 1892-1898.
  • 23 Kyaw T, Tay C, Hosseini H. et al. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS One 2012; 7: e29371.
  • 24 Kyaw T, Tay C, Khan A. et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010; 185: 4410-4419.
  • 25 Sage AP, Tsiantoulas D, Baker L. et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice--brief report. Arterioscler Thromb Vasc Biol 2012; 32: 1573-1576.
  • 26 Hayakawa K, Hardy RR. Development and function of B-1 cells. Curr Opin Immunol 2000; 12: 346-353.
  • 27 Kyaw T, Tay C, Krishnamurthi S. et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011; 109: 830-840.
  • 28 Binder CJ, Shaw PX, Chang MK. et al. The role of natural antibodies in athero-genesis. J Lipid Res 2005; 46: 1353-1363.
  • 29 Kantor AB, Herzenberg LA. Origin of murine B cell lineages. Ann Rev Immunol 1993; 11: 501-538.
  • 30 Mauri C, Bosma A. Immune regulatory function of B cells. Ann Rev Immunol 2012; 30: 221-241.
  • 31 DiLillo DJ, Horikawa H, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res 2011; 49: 281-292.
  • 32 Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011; 11: 34-46.
  • 33 Ait-Oufella H, Herbin O, Bouaziz JD. et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010; 207: 1579-1587.
  • 34 Shaw PX, Horkko S, Chang MK. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105: 1731-1740.
  • 35 An G, Wang H, Tang R. et al. P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation 2008; 117: 3227-3237.
  • 36 Leon B, Ardavin C. Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood 2008; 111: 3126-3130.
  • 37 Robbins CS, Hilgendorf I, Weber GF. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 2013; 19: 1166-1172.
  • 38 Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res 2012; 110: 875-888.
  • 39 Stadtmann A, Germena G, Block H. et al. The PSGL-1-L-selectin signaling complex regulates neutrophil adhesion under flow. J Exp Med 2013; 210: 2171-2180.
  • 40 Grailer JJ, Kodera M, Steeber DA. L-selectin: role in regulating homeostasis and cutaneous inflammation. J Dermatol Sci 2009; 56: 141-147.
  • 41 Eriksson EE, Xie X, Werr J. et al. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med 2001; 194: 205-218.
  • 42 McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002; 14: 581-586.
  • 43 Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 2005; 17: 244-250.
  • 44 Marino E, Batten M, Groom J. et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 2008; 57: 395-404.
  • 45 Eriksson EE. Intravital microscopy on atherosclerosis in apolipoprotein e-deficient mice establishes microvessels as major entry pathways for leukocytes to advanced lesions. Circulation 2011; 124: 2129-2138.
  • 46 Mulligan-Kehoe MJ. The vasa vasorum in diseased and nondiseased arteries. Am J Physiol Heart Circ Physiol 2010; 298: H295-H305.
  • 47 Xu J, Grewal IS, Geba GP. et al. Impaired primary T cell responses in L-selectin-deficient mice. J Exp Med 1996; 183: 589-598.
  • 48 Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011; 11: 119-130.